Sunday, November 15, 2009

Social Media and Pharma

The Food and Drug Administration (FDA) recently held a public hearing to provide an opportunity for broad public participation and comment on promotion of FDA-regulated medical products (including prescription drugs for humans and animals, prescription biologics, and medical devices) using the Internet and social media tools. The two day hearing - which was live cast and Tweeted - wass intended to help guide the FDA's policy decisions, especially in the areas of social media tools and search.

FDA is seeking participation in the public hearing and written comments from all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, Internet vendors, advertising agencies, and the regulated industry. This meeting and written comments are intended to help guide FDA in making policy decisions on the promotion of human and animal prescription drugs and biologics and medical devices using the Internet and social media tools. You can submit your comments on the FDA website here.

Here is an intresting background article to read:
Why Pharma Stays Stuck in the Web's Past

And if you missed #fdasm? Here is the complete twitter transcript for the 2 days:

FDA will likely issue a draft guidance document following the comment period for the public hearing.

Google FDA Public Hearing

Complete coverage of the FDA public hearings on internet and social media

.. and some more related articles from Reuters and HBR.
FDA tackles gray area of social media

The FDA, Big Pharma, and Social Media: What's the Right Rx?

No comments: